Navigation Links
Novel connection found between biological clock and cancer

Dartmouth Medical School geneticists have discovered that DNA damage resets the cellular circadian clock, suggesting links among circadian timing, the cycle of cell division, and the propensity for cancer.

Their work, reported June 29 in Science Express, the advance electronic publication of Science, implies a protective dimension for the biological clock in addition to its pacemaker functions that play such a sweeping role in the rhythms and activities of life.

"The notion that the clock regulates DNA-damage input and that mutation can affect the clock as well as the cell cycle is novel," says Jay Dunlap, professor and chair of genetics at DMS. "It suggests a fundamental connection among circadian timing, cell cycle progress, and potentially the origins of some cancers."

Dunlap is a co-author of the paper with DMS colleagues, Jennifer Loros, professor of biochemistry, graduate student Christopher L. Baker, and former students António M. Pregueiro and Qiuyun Liu.

The team of Loros and Dunlap were among to first to delineate the intricate web of clockwork genes, proteins and feedback loops that drive circadian rhythms, working chiefly in the classic genetic model organism Neurospora, the common bread mold.

One gene (period-4) was identified over 25 years ago by a mutation that affects two clock properties, shortening the circadian period and altering temperature compensation. For this study, the researchers cloned the gene based on its position in the genome, and found it was an important cell cycle regulator. When they eliminated the gene from the genome, the clock was normal, indicating that the mutation interfered in some way with the clock, rather than supplying something that the clock normally needs to run.

Biochemically, the mutation results in a premature modification of the well understood clock protein, frequency (FRQ). The investigators demonstrated that this was a direct result of action by an enzyme, called
'"/>

Source:Dartmouth Medical School


Page: 1 2

Related biology news :

1. Novel Asthma Study Shows Multiple Genetic Input Required; Single-gene Solution Shot Down
2. Novel technology detects human DNA mutations
3. Novel antiviral technology inhibits RSV infection in mice
4. Novel Enzyme Shows Potential As An Anti-HIV Target
5. Novel Therapy Tested in Mice Could Chase Away Cat Allergies
6. Discovery Could Lead To Novel Approaches In HIV Treatment
7. Novel ultrafast laser detection of cancer cells also may improve understanding of stem cells
8. Research Using Mouse Models Reveals A Novel Key Player In The Initiation Of Colon Cancer
9. Novel gene-silencing nanoparticles shown to inhibit Ewings sarcoma
10. Novel live reporting system to track cells
11. Field of beams - Novel system uses polarized light pulses to reveal crop health

Post Your Comments:
(Date:12/2/2009)...urance of a cancer-free status did not prompt peop...raphy (CT) lung-cancer screening program to pick u...tudy published in Cancer Epidemiology, Biomarkers...ion for Cancer Research. The December issue contai...should negate widespread concern in the lung scree...
(Date:12/2/2009)...e University Medical Center researchers have figur...r glioma may be better able to resist radiation th...aling pathway in these cancer stem cells, they wer...on in a laboratory experiment. , The work build...em cells resist the effects of radiation much bett...
(Date:12/2/2009)...reporting the first identification of substances i... changes harmless marine bacteria into killers tha...ACS, Environmental Science & Technology , a semi-...te that bleaching already has destroyed up to 30 p...are searching for ways to slow or stop the damage....
Breaking Biology News(10 mins):Repeat negative CT scan for lung cancer does not encourage ex-smokers to resume the habit 2Discovery makes brain tumor cells more responsive to radiation 2Big Top Cupcake 28TM 29 Brand Awarded With Guinness World Record For Worlds Largest Cupcake 59088 1Big Top Cupcake 28TM 29 Brand Awarded With Guinness World Record For Worlds Largest Cupcake 59088 2National Health Care Reformers Should Pay Attention to Lawsuit Alleging that Nations Largest Insurer Routinely Denies Liver Transplants 59086 1National Health Care Reformers Should Pay Attention to Lawsuit Alleging that Nations Largest Insurer Routinely Denies Liver Transplants 59086 2BayCare Behavioral Health and Homeless Emergency Project Receive Federal Grant to Help Break the Cycle of Homelessness 59084 1BayCare Behavioral Health and Homeless Emergency Project Receive Federal Grant to Help Break the Cycle of Homelessness 59084 2BayCare Behavioral Health and Homeless Emergency Project Receive Federal Grant to Help Break the Cycle of Homelessness 59084 3
...logy have developed a prosthetic vein valve to hel...ition known as chronic venous insufficiency. The c...ople in the United States alone, occurs when valve...ay flow of blood back to the heart. , "Blood fl...ses vein valves to pump blood in one direction bac...
...ORTCNCIAACR Symposium on "Molecular Targets and Ca...Palexpo, Geneva] from Tuesday 21 October-Friday 24...adline for booking accommodation via the official ...organised jointly by the European Organisation for...onal Cancer Institute and the American Association...
...trial of a catheter-based treatment for deep vein ... drugs in combination with clot removal devices to... DVT (the formation of a blood clot in a leg vein)...causes permanent damage to the veins, resulting in...and/or skin ulcers. About 25�� perce...
Other Biology News:Prosthetic vein valve designed to direct blood flow shows promising pre-clinical results 2Prosthetic vein valve designed to direct blood flow shows promising pre-clinical results 3Prosthetic vein valve designed to direct blood flow shows promising pre-clinical results 4Media invitation: 20th EORTC-NCI-ACR Symposium on Molecular Targets and Cancer Therapeutics 2Pivotal national trial uses newest interventional radiology treatment to bust blood clots in legs 2Pivotal national trial uses newest interventional radiology treatment to bust blood clots in legs 3
(Date:12/1/2009)..., Dec. 1 Reportlinker.com announce...n its catalogue: ,, Chromium - Global Market ...94/Chromium---Global-Market-Trends.html ,, Wor... by stainless steel, while growth in aerospace and...for growth of chromium metal. Environmental constr...
(Date:12/1/2009)..., Dec. 1 Reportlinker.com announce...n its catalogue: ,, Emerging Clinical Trial Lo...changing healthcare and regulatory environment ,...-Clinical-Trial-Locations---Eastern-Europe-Market-...y-environment.html ,, Over the last decade pha...
(Date:12/1/2009)...GE, Mass., Dec. 1 To address the e...promote its potential, a group of individuals and ... Biology Industry Association (SynBIA) in Cambridg...ation is to provide a forum for individuals and co...dress its opportunities and its challenges, and ad...
(Date:12/1/2009)... Dec. 1 /PRNewswire-Asia/ -- Shanghai ChemPartner,...ing China-based Contract Research,Organization (CR...oitte,Technology Fast 50 China, ranking 3rd on the...n China. The award is a testament to ChemPartner,s...o 2008. , The results of the 2009 Deloitt...
Breaking Biology Technology:Reportlinker Adds Chromium - Global Market Trends 2Reportlinker Adds Chromium - Global Market Trends 3Reportlinker Adds Chromium - Global Market Trends 4Reportlinker Adds Chromium - Global Market Trends 5Reportlinker Adds Chromium - Global Market Trends 6Reportlinker Adds Chromium - Global Market Trends 7Reportlinker Adds Chromium - Global Market Trends 8Reportlinker Adds Chromium - Global Market Trends 9Reportlinker Adds Emerging Clinical Trial Locations - Eastern Europe: Market Dynamics and the Changing Healthcare and Regulatory Environment 2Reportlinker Adds Emerging Clinical Trial Locations - Eastern Europe: Market Dynamics and the Changing Healthcare and Regulatory Environment 3Reportlinker Adds Emerging Clinical Trial Locations - Eastern Europe: Market Dynamics and the Changing Healthcare and Regulatory Environment 4Reportlinker Adds Emerging Clinical Trial Locations - Eastern Europe: Market Dynamics and the Changing Healthcare and Regulatory Environment 5Reportlinker Adds Emerging Clinical Trial Locations - Eastern Europe: Market Dynamics and the Changing Healthcare and Regulatory Environment 6Reportlinker Adds Emerging Clinical Trial Locations - Eastern Europe: Market Dynamics and the Changing Healthcare and Regulatory Environment 7Reportlinker Adds Emerging Clinical Trial Locations - Eastern Europe: Market Dynamics and the Changing Healthcare and Regulatory Environment 8Industry Forms Association to Address Opportunities and Challenges of Synthetic Biology 2Shanghai ChemPartner Ranks 3rd among 2009 Deloitte Technology Fast 50 China Winning Companies 2Shanghai ChemPartner Ranks 3rd among 2009 Deloitte Technology Fast 50 China Winning Companies 3
...TON, N.H., May 21 The American Acne & Rosacea...nt of National Acne Awareness Month which will occ...AARS, James Q. Del Rosso, DO, President, stated th...pportunity to educate healthcare providers concern...s for this disease which affects over 17 million A...
...ersal Definition of Myocardial Infarction provided...ties , , TOKYO and INDIANAPOLIS, May 21 Investig...ied the new classification system for the Universa...ts of the study and showed that patients with acut... coronary intervention (PCI) and taking prasugrel,...
...oved for peripheral neuropathic pain in non-diabet...X, Inc. (Nasdaq: NGSX ), a biopharmaceutical com...el pain management therapies, announced today that...eting authorization of Qutenza(TM) 179 mg cutaneou...eripheral neuropathic pain in non-diabetic adults ...
Other Biology Technology:American Acne & Rosacea Society Announces Acne Awareness Month - June 2009 2Multiple Types of Heart Attacks Reduced by Prasugrel in TRITON-TIMI 38 Trial 2Multiple Types of Heart Attacks Reduced by Prasugrel in TRITON-TIMI 38 Trial 3Multiple Types of Heart Attacks Reduced by Prasugrel in TRITON-TIMI 38 Trial 4Multiple Types of Heart Attacks Reduced by Prasugrel in TRITON-TIMI 38 Trial 5Multiple Types of Heart Attacks Reduced by Prasugrel in TRITON-TIMI 38 Trial 6NeurogesX Receives European Commission Approval for Qutenza(TM) 2NeurogesX Receives European Commission Approval for Qutenza(TM) 3NeurogesX Receives European Commission Approval for Qutenza(TM) 4NeurogesX Receives European Commission Approval for Qutenza(TM) 5
Mouse Anti-Hamartin Monoclonal Antibody, Unconjugated, Clone 1B2 from Cell Signaling Technology
Blank Calibration Particles, 3.0-3.4 mu m from BD Biosciences Pharmingen
Rabbit Anti-Human SYT16 Polyclonal Antibody, Unconjugated from Atlas Antibodies
Anti-IL-12 / IL-23 Monoclonal Antibody, Alexa Fluor 647 Conjugated, Clone C17.8 from eBioscience
Biology Products: